Cutaneous sarcoidosis due to immune‐checkpoint inhibition and exacerbated by a novel BRAF dimerization inhibitor

por J. P. Pham, P. Star, S. Wong, D. L. Damian, R. P. M. Saw, M. J. Whitfeld, A. M. Menzies, A. M. Joshua, A. Smith
Publicado 2021